SAR-444836

N/A

Report date: 2026/01/23 17:21:57

Base Information

Drug NameSAR-444836
Drug Alias NamePAH replacement AAV-based gene therapy(Sanofi)SAR-444836SAR444836
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPhenylalanine hydroxylase modulators
TargetsPhenylalanine hydroxylase
Therapy Area/IndicationsPhenylketonurias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesArgentinaBrazil +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsPhenylketonurias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A